These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29684916)

  • 21. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
    Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
    J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: interest of the Deco questionnaire.
    Carcaillon L; Berrut G; Sellal F; Dartigues JF; Gillette S; Pere JJ; Bourdeix I
    J Nutr Health Aging; 2011 May; 15(5):361-6. PubMed ID: 21528162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.
    Sona A; Zhang P; Ames D; Bush AI; Lautenschlager NT; Martins RN; Masters CL; Rowe CC; Szoeke C; Taddei K; Ellis KA;
    Int Psychogeriatr; 2012 Feb; 24(2):197-204. PubMed ID: 21749739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
    Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
    Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delusions and hallucinations are associated with worse outcome in Alzheimer disease.
    Scarmeas N; Brandt J; Albert M; Hadjigeorgiou G; Papadimitriou A; Dubois B; Sarazin M; Devanand D; Honig L; Marder K; Bell K; Wegesin D; Blacker D; Stern Y
    Arch Neurol; 2005 Oct; 62(10):1601-8. PubMed ID: 16216946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Affecting Rapid Cognitive Decline in Patients with Alzheimer's Disease: A Longitudinal Follow-Up Study.
    Pan CC; Chu CS; Chen CL; Chuang YC; Chen NC
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease.
    Aubert L; Pichierri S; Hommet C; Camus V; Berrut G; de Decker L
    J Am Geriatr Soc; 2015 Mar; 63(3):543-7. PubMed ID: 25752337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological predictors of rapidly progressive Alzheimer's disease.
    Tosto G; Gasparini M; Brickman AM; Letteri F; Renie' R; Piscopo P; Talarico G; Canevelli M; Confaloni A; Bruno G
    Acta Neurol Scand; 2015 Dec; 132(6):417-22. PubMed ID: 25903925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
    Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).
    Herrmann N; Harimoto T; Balshaw R; Lanctôt KL;
    Can J Psychiatry; 2015 Apr; 60(4):189-99. PubMed ID: 26174219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.
    Sourdet S; van Kan GA; Soto ME; Houles M; Cantet C; Nourhashemi F; Vellas B; Pahor M; Rolland Y
    J Am Med Dir Assoc; 2012 May; 13(4):407.e1-6. PubMed ID: 22227074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.
    Barocco F; Spallazzi M; Concari L; Gardini S; Pelosi A; Caffarra P
    J Alzheimers Dis; 2017; 57(3):775-786. PubMed ID: 28304306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mini-Mental State Examination score trajectories and incident disabling dementia among community-dwelling older Japanese adults.
    Taniguchi Y; Kitamura A; Murayama H; Amano H; Shinozaki T; Yokota I; Seino S; Nofuji Y; Nishi M; Yokoyama Y; Matsuyama Y; Fujiwara Y; Shinkai S
    Geriatr Gerontol Int; 2017 Nov; 17(11):1928-1935. PubMed ID: 28296176
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.